Bing

NEW YORK (TheStreet) -- Vical (VICL - Get Report) shares are gaining ... also received a $4.65 price target which represents a potential upside of 355% from the stock's current price. The firm is very optimistic about the treatments currently being ...
The Street · 6/2/2015
What's up with Vical's (NASDAQ:VICL) stock? There's no question the market has been treating it like the red-headed stepchild since the company's former lead product, Allovectin 7, failed its Phase 3 trial late last summer. But yesterday, as you can see ...
Seeking Alpha · ByTheodore Cohen · 1/15/2014
SAN DIEGO, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL), a biotechnology company developing ... any intent or obligation to update these forward-looking statements. Stock Market XML and JSON Data API provided by …
Financial Content · 8/19/2015
Infectious Disease Product
More from Bing News
The stock should find initial resistance at its 50-day moving average ... Shares of Vical Fall to a New 52-Week Lo... Shares of Vical (NASDAQ:VICL) traded today at $0.57, breaking its 52-week low. So far ... VirnetX Holding (AMEX:VHC) traded at a new ...
Financial News Network Online · ByPeter Chu · 8/22/2015
Valmont Industries
Several research analysts have commented on VICL shares. Zacks downgraded shares of Vical from a “hold” rating to a “sell” rating in a report on Wednesday. HC Wainwright set a $2.50 target price on shares of Vical and gave the stock a “buy ...
sleekmoney.com · 7/31/2015
The business’s revenue was down 6.7% on a year-over-year basis. Shares of Vical (NASDAQ:VICL) opened at 0.64 on Thursday. The stock’s market cap is $58.49 million. The stock has a 50 day moving average of $0.87 and a 200 day moving average of …
Ticker Report · 7/30/2015
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Vical Incorporated (VICL). This Biotech stock has actually seen loss estimates narrowing from a loss of 32 cents to a loss of 22 cents now over ...
Yahoo Finance · 3/12/2014
Vical Incorporated ( VICL) was a big mover last session, as its shares rose almost 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the healthcare …
NASDAQ · 1/13/2014
Several other brokerages have also recently issued reports on VICL. HC Wainwright set a $2.50 target price on shares of Vical and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Roth Capital lowered shares of Vical from a ...
Mideast Times · 7/31/2015
Investors certainly have to be happy with Vical Incorporated (VICL - Snapshot Report) and its short term performance. After all, the stock has jumped by 40.4% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is ...
ZACKS · 6/10/2015